期刊文献+

84例抗凝药物致不良反应的帕累托图分析 被引量:4

Pareto Chart Analysis of 84 Cases of Adverse Reactions Caused by Anticoagulants
下载PDF
导出
摘要 目的:分析抗凝药物不良反应(ADR)发生的规律、特点,探讨ADR发生与变化的可能原因及影响因素,为临床应用提供参考。方法:对上海交通大学附属第一人民医院2012年1月-2018年12月上报至国家药品不良反应监测系统的84例抗凝药物所致ADR进行帕累托图分析。结果:84例抗凝药物ADR报告中,男性比例较高为46例(54.76%);60岁以上人群ADR发生例次较多,有62例(73.81%);新的ADR报告4例(4.76%),严重的ADR报告19例(22.62%);发生ADR的抗凝药物共4个种类,其中低分子肝素类药物最多(41.84%),其次为维生素K拮抗剂类(27.55%);以血液系统损害最为常见(74.23%);以药师上报为主。结论:抗凝药物引发ADR与多种因素有关,临床用药时应全方位监控,以减少ADR的发生,确保用药安全。 Objective:To analyze regularity,characteristics,causes and influence factors of adverse drug reactions(ADRs)of anticoagulants so as to provide references for clinical application.Methods:Pareto chart analysis to 84 cases of ADRs caused by anticoagulants from January,2012 to December,2018 was reported to the National Adverse Drug Reaction Monitoring System by Shanghai General Hospital affiliated to Shanghai Jiao Tong University.Results:Among 84 cases of ADRs reported,46 cases(54.76%)were male,62 cases(73.81%)were over 60 years old,4 cases(4.76%)were new ADRs reports,and 19 cases(22.62%)were serious ADRs reports.Four kinds of anticoagulants were involved,among which low molecular weight heparins accounted for the highest proportion(41.84%),followed by vitamin antagonists(27.55%).The damage of blood system was the most common occurrence(74.23%),and the pharmacists were the main reporters.Conclusion:ADRs induced by anticoagulants were related to multiple factors,so we should strengthen monitoring in all aspects in order to reduce the occurrence of ADRs and ensure the safety of medication.
作者 马玉 席宇飞 康雷 李琴 范国荣 熊学惠 Ma Yu;Xi Yufei;Kang Lei;Li Qin;Fan Guorong;Xiong Xuehui(Shanghai General Hospital,Shanghai Jiao Tong University,Shanghai 201620,China;Department of Pharmacy,The Second People's Hospital of Wuhu,Wuhu 241000,China)
出处 《中国药事》 CAS 2020年第3期363-370,共8页 Chinese Pharmaceutical Affairs
基金 上海交通大学医学院医院药学科研基金项目(编号JDYX2016QN010).
关键词 抗凝药物 药品不良反应 帕累托图分析 用药安全 anticoagulants adverse drug reactions Pareto chart analysis drug safety
  • 相关文献

参考文献11

二级参考文献152

  • 1张彦丽,王景红,顾媛媛,桂班月.华法林与中草药的相互作用[J].中国药物警戒,2011,8(1):41-45. 被引量:31
  • 2许俊堂.口服抗凝药的作用机制与临床应用(上)[J].中国医刊,2006,41(1):51-52. 被引量:22
  • 3邱贵兴,杨庆铭,余楠生,翁习生,王凯,李晓林.低分子肝素预防髋、膝关节手术后下肢深静脉血栓形成的多中心研究[J].中华骨科杂志,2006,26(12):819-822. 被引量:426
  • 4陈东峰,余楠生,卢伟杰,白波.低分子肝素联合间歇充气加压预防人工关节置换术后下肢深静脉血栓形成[J].中华骨科杂志,2006,26(12):823-826. 被引量:98
  • 5王丽姿,张建宁,刘子先,姜红.医院门诊药房服务流程再造的实践[J].中华医院管理杂志,2007,23(3):164-166. 被引量:11
  • 6Hashash JG, Shamseddeen W, Skoury A. Gross lower gastrointestinal bleeding in patients on anticoagulant and/or anti-platelet therapy:endoscopic findings, management, and clinical Outcomes [ J]. J Clin Gastroenterol, 2009, 43 ( 1 ) : 36-42.
  • 7Bhatt DL, Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use : a report of the American college of cardiology foundation task force on clinical expert consensus documents [ J ]. Circulation, 2008, 118 ( 18 ) : 1894-1909.
  • 8Canadian Cardiovascular Society, American Academy of Family Physicians, American College of Cardiology, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST- elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [ J]. J Am Coll Cardiol, 2008, 51 (10) : 210-247.
  • 9Wysowski DK, Nourjah P, Swartz L. Bleeding complications with Warfarin use: a prevalent adverse effect resulting in regulatory action [ J]. Arch Intern Med, 2007, 167(13): 1414-1419.
  • 10Ibanez L, Vidal X, Lvendrel L, et al. Upper gastrointestinal bleeding associated with anti-platelet drugs [ J ]. Aliment Pharmacol Ther, 2006, 23(2) : 235-242.

共引文献581

同被引文献38

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部